Jeff E. Knight - 30 Aug 2021 Form 3 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role: Chief Operating Officer
Signature: /s/ Marc Wilson, as attorney-in-fact
Issuer symbol: CRNX
Transactions as of: 30 Aug 2021
Net transactions value: $0
Form type: 3
Filing time: 02 Sep 2021, 17:00:21 UTC
Next filing: 02 Sep 2021
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney